Niraxostat - Y700 | Piraxostat

Based on 16 reference(s) in Google Scholar 9 10 16

Axon 1174

CAS [206884-98-2]

MF C16H17N3O3
MW 299.32

  • Purity: 99%
  • Soluble in DMSO



Xanthine oxidase (XO) inhibitor. Niraxostat demonstrated high oral bioavailability being predominantly eliminated via the liver. It potently reduces serum uric acid levels. Niraxostat was in clinical trials for the treatment of gout.

KEYWORDS: Niraxostat | Supplier | XO inhibitor | Y700 | Piraxostat | Y 700 | Y-700 | CAS [206884-98-2] | Hypoxanthine | Xanthine Oxidase | Inhibitor | Enzymes


Size Unit Price Stock
5 mg €130.00 In Stock
25 mg €480.00 In Stock
Special Offers
Size Unit Price Stock
2 x 5 mg €200.00 In Stock
Need more? Bulk Inquiry

The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.

Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!

Please wait...